Pharmacology mechanism of Flos magnoliae and Centipeda minima for treating Allergic Rhinitis based on Pharmacology network.

Pharmacology mechanism of Flos magnoliae and Centipeda minima for treating Allergic Rhinitis based on Pharmacology network. Drug Dev Ind Pharm. 2019 Jun 20;:1-23 Authors: Liang Y, Zhang X, Zou J, Shi Y, Wang Y, Tai J, Yang Y, Zhou X, Guo D, Wang J, Cheng J, Yang M Abstract Chinese herbs such as Flos magnoliae (FM) and Centipeda minima (CM) can be effective in treating allergic rhinitis (AR). However, there is little research on the therapeutic mechanism of these two drugs acting on AR at the same time. In order to systematically understand the mechanism of action of two drugs acting on AR at the same time, we searched various databases to obtain 31 components and 289 target proteins of FM, 25 components and 465 target proteins of CM. The interaction networks of FM, CM and AR proteins were constructed by Cytoscape-v3. 2. 1 software. The core protein of two network intersections was obtained by using Venny 2.1.0. The R platform was used for the core target protein GO (Gene Ontology) comment analysis and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis. 13 common targets and 7 acting pathways were obtained. The results of animal experiments showed that FM and CM volatile oil could effectively improve the symptoms of AR by regulating the common targets. In summary, this study successfully explained the potential therapeutic mechanism of FM and CM in the treatment of AR. At the same time, it indicates that the two drugs can...
Source: Drug Development and Industrial Pharmacy - Category: Drugs & Pharmacology Tags: Drug Dev Ind Pharm Source Type: research